High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.
about
Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challengesLong-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts.Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysisLipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern IndiaPrevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapyA Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational SettingsHigh Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral TherapyAbacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model.Metabolic complications and treatment of perinatally HIV-infected children and adolescents.Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily.Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children.Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland.Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study
P2860
Q27022471-F0D62905-162D-4298-A0A9-5FD480570DA0Q30978868-60BC6A35-1AC8-4BB8-A324-69A975532A41Q33624953-EE42B8A2-7EE5-41F4-98EF-22978D8F3CF5Q34335535-99A30F92-DD01-4408-A30D-32840C74827DQ35205900-DCCEB3E7-000A-4403-87E4-FC6219666AE2Q35881469-1D8FD476-E8C7-41A5-89D5-4756E2D5161BQ36449095-0FA81EA7-27CA-4AF1-A09F-99A3C7DFD222Q36501872-F6045916-DEE3-4E08-BAAD-05AF03986749Q36558893-B34041C9-4A71-46D8-9123-EA2C24343D39Q36952291-9F2F365B-60DD-43CE-B61C-E969A825440DQ37544710-7DD2C8CC-232D-45E5-9878-B236B992A406Q37724319-2AEA09FE-7AF1-49C4-B076-2B7A1F3091B9Q38798094-79B18E66-0260-438F-AC5F-7436C95D9F8EQ53695978-B8F2DA84-DD06-40A9-A623-5FD17993CAA0Q58798902-7056BD52-DC5B-41C6-8AC1-53999C206190
P2860
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@ast
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@en
type
label
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@ast
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@en
prefLabel
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@ast
High prevalence of lipoatrophy ...... rapy: a cross-sectional study.
@en
P2093
P2860
P356
P1433
P1476
High prevalence of lipoatrophy ...... erapy: a cross-sectional study
@en
P2093
Clair Edson
Ekkehard W Zöllner
Margaret van Niekerk
Maria M Conradie
Mark F Cotton
Richard Haubrich
Sara H Browne
Sonia Jain
Stephen Hough
Xiaoying Sun
P2860
P2888
P356
10.1186/1471-2431-12-183
P577
2012-11-23T00:00:00Z
P5875
P6179
1004665511